CVRdatabase
Menu

Gunnar Kjems ApS

Private limited companyCVR 52893119København KActive

Gunnar Kjems ApS is a private limited company, based in København K, active in manufacture of pharmaceutical preparations, founded in 1975. Net profit rose 2192% from 2024 to 2025, ending at DKK 311k. Equity grew to DKK 1.4m in 2025. The company has existed for over 50 years.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 5.9m−0.1% vs. 2024
Net profitDKK 311k+2,191.9% vs. 2024
EquityDKK 1.4m+29.4% vs. 2024
Employees4latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 1,766% (2024 → 2025), to DKK 266k.
  • Net profit rose 2,192% (2024 → 2025), to DKK 311k.
  • Equity rose 29% (2024 → 2025), to DKK 1.4m.

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 200kDKK 400kDKK 600kDKK 800kDKK 1mDKK 1.2mDKK 1.4m202020212022202320242025
EquityNet profit
Financial figures for Gunnar Kjems ApS
202020212022202320242025Change
Revenue4,8215,7176,2305,8065,9185,911−0.1%
Gross profit−34252257−2814266+1,765.9%
Operating profit (EBIT)−43242248−369266+2,984.1%
Profit before tax52293272914392+2,788.1%
Net profit11782552914311+2,191.9%
Total assets2,2182,1442,5121,9371,9572,183+11.5%
Equity5847621,0171,0461,0591,371+29.4%
Liabilities1,6341,3821,495891898812−9.6%
Cash and cash equivalents886344647111013−87.9%
Average number of employees111110−100%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 500kDKK 0DKK 500kDKK 1mDKK 1.5mDKK 2mDKK 2.5mDKK 3m202020212022202320242025
Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Gunnar Kjems ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202529/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202401/07/2025The companyPDFXBRL
202301/01/2023 – 31/12/202321/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202227/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202124/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202025/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
012345608/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profitDKK 266kNo. 34 of 57
Better than 41% of the companies in the industry
EquityDKK 1.4mNo. 39 of 59
Better than 34% of the companies in the industry
Number of employees4No. 52 of 59
Better than 12% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bn
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 58,338of 69,742
Better than 16%
No. 29,403of 69,964
Better than 58%
Same industry and fewer than 20 employees37 companies in the comparison
No. 16of 36
Better than 57%
No. 20of 37
Better than 47%
Companies that are at least 30 years old10,276 companies in the comparison
No. 9,001of 10,152
Better than 11%
No. 8,432of 10,275
Better than 18%
All companies of type ApS66,508 companies in the comparison
No. 56,118of 66,379
Better than 15%
No. 25,348of 66,505
Better than 62%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. Gunnar Kjems ApSDKK 266k
  2. Novo Nordisk A/SDKK 250.3bn
  3. H. Lundbeck A/SDKK 20.4bn
Net profit
  1. Gunnar Kjems ApSDKK 311k
  2. Novo Nordisk A/SDKK 102.4bn
  3. H. Lundbeck A/SDKK 3.2bn
Equity
  1. Gunnar Kjems ApSDKK 1.4m
  2. Novo Nordisk A/SDKK 194bn
  3. H. Lundbeck A/SDKK 24.9bn
Employees
  1. Gunnar Kjems ApS4
  2. Novo Nordisk A/S27,279
  3. H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Gunnar Kjems ApS

Management

2 active registrations

Executive management

Executive management at Gunnar Kjems ApS
NameRoleAppointed
Gunnar KjemsDirector21/05/1975
Trine Bente KjemsDirector21/05/1975
Auditor
Buus Jensen I/S Statsautoriserede Revisorer

Signing rule: Selskabet tegnes af en direktør alene

Address and production units

1 active production units

Peder Hvitfeldts Stræde 12
1173 København K

København Municipality · Postcode 1173

Production units
Production unitAddressEmployeesP number
GUNNAR KJEMS APSPeder Hvitfeldts Stræde 12, 1173 København K41001996112

Purpose

Selskabets formål er fabrikation, handel, financiering og hermed beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

16 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20251 changeaccounts 1
  • Annual report for 2024 published
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20201 changeaddress 1
  • Moved to Peder Hvitfeldts Stræde 12, 1173 København K
20081 changeindustry 1
  • Industry changed to Manufacture of pharmaceutical preparations (212000)
20061 changeindustry 1
  • Industry changed to Aluminium production (244200)
19961 changecapital 1
  • Share capital changed from 80,000 DKK to 200,000 DKK
19756 changesfounded 1 · management 2 · ownership 3
  • Registered as GUNNAR KJEMS ApS
  • Gunnar Kjems appointed director
  • Trine Bente Kjems appointed director
  • Gunnar Kjems registered as owner (100%)
  • Gunnar Kjems is no longer registered as owner
  • Gunnar Kjems registered as owner (100%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction